Madrona Financial Services LLC Buys 28,457 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Madrona Financial Services LLC increased its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 786.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 32,075 shares of the financial services provider’s stock after purchasing an additional 28,457 shares during the period. iShares Biotechnology ETF accounts for 1.2% of Madrona Financial Services LLC’s portfolio, making the stock its 24th largest holding. Madrona Financial Services LLC’s holdings in iShares Biotechnology ETF were worth $4,241,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also recently bought and sold shares of IBB. Hsbc Holdings PLC raised its position in iShares Biotechnology ETF by 47.1% in the 2nd quarter. Hsbc Holdings PLC now owns 3,670 shares of the financial services provider’s stock worth $504,000 after purchasing an additional 1,175 shares during the last quarter. AE Wealth Management LLC grew its holdings in iShares Biotechnology ETF by 10.7% during the 2nd quarter. AE Wealth Management LLC now owns 2,034 shares of the financial services provider’s stock worth $279,000 after acquiring an additional 196 shares during the period. Bank of Montreal Can grew its holdings in iShares Biotechnology ETF by 2.6% during the 2nd quarter. Bank of Montreal Can now owns 36,198 shares of the financial services provider’s stock worth $5,086,000 after acquiring an additional 920 shares during the period. Prairie Wealth Advisors Inc. grew its holdings in iShares Biotechnology ETF by 6.0% during the 2nd quarter. Prairie Wealth Advisors Inc. now owns 1,765 shares of the financial services provider’s stock worth $242,000 after acquiring an additional 100 shares during the period. Finally, Security National Bank of SO Dak grew its holdings in shares of iShares Biotechnology ETF by 0.7% in the 2nd quarter. Security National Bank of SO Dak now owns 10,461 shares of the financial services provider’s stock valued at $1,436,000 after buying an additional 75 shares during the period. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

Shares of IBB stock opened at $135.78 on Thursday. iShares Biotechnology ETF has a 12-month low of $123.60 and a 12-month high of $150.57. The firm has a fifty day moving average of $136.00 and a 200-day moving average of $141.81.

iShares Biotechnology ETF Cuts Dividend

The business also recently announced a dividend, which was paid on Friday, December 20th. Investors of record on Tuesday, December 17th were paid a $0.0624 dividend. The ex-dividend date was Tuesday, December 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.